Categories Multiple Myeloma

New treatment for patients with relapsed/refractory multiple myeloma

New treatment for patients with relapsed/refractory multiple myeloma For patients with multiple myeloma resistant to available therapies, an experimental drug studied by an international, multi-center team led by Winship’s Sagar Lonial, MD, displayed a 31 percent overall response rate and is thus a significant new option. Learn about multiple myeloma care at Winship, visit https://winshipcancer.emory.edu/multiple-myeloma.

Read More
Categories Uncategorized

The Cholesterol And Heart Disease Connection

”; Coronary heart disease, also referred to as coronary artery disease (CAD), is the most common form and represents 54 percent of all cardiovascular diseases. Coronary artery disease includes angina pectoris, which is chest pain from narrowing of blood vessels, and myocardial infarction (MI), also known as a heart attack, from the complete block­age of […]

Read More